1. Home
  2. IOVA vs THRM Comparison

IOVA vs THRM Comparison

Compare IOVA & THRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOVA
  • THRM
  • Stock Information
  • Founded
  • IOVA 2007
  • THRM 1991
  • Country
  • IOVA United States
  • THRM United States
  • Employees
  • IOVA N/A
  • THRM N/A
  • Industry
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • THRM Auto Parts:O.E.M.
  • Sector
  • IOVA Health Care
  • THRM Consumer Discretionary
  • Exchange
  • IOVA Nasdaq
  • THRM Nasdaq
  • Market Cap
  • IOVA 975.1M
  • THRM 1.0B
  • IPO Year
  • IOVA N/A
  • THRM 1993
  • Fundamental
  • Price
  • IOVA $2.68
  • THRM $31.81
  • Analyst Decision
  • IOVA Buy
  • THRM Buy
  • Analyst Count
  • IOVA 10
  • THRM 3
  • Target Price
  • IOVA $12.22
  • THRM $46.00
  • AVG Volume (30 Days)
  • IOVA 26.0M
  • THRM 320.5K
  • Earning Date
  • IOVA 08-07-2025
  • THRM 07-24-2025
  • Dividend Yield
  • IOVA N/A
  • THRM N/A
  • EPS Growth
  • IOVA N/A
  • THRM N/A
  • EPS
  • IOVA N/A
  • THRM 1.02
  • Revenue
  • IOVA $212,679,000.00
  • THRM $1,453,370,000.00
  • Revenue This Year
  • IOVA $86.62
  • THRM N/A
  • Revenue Next Year
  • IOVA $69.13
  • THRM $4.04
  • P/E Ratio
  • IOVA N/A
  • THRM $31.28
  • Revenue Growth
  • IOVA 11070.12
  • THRM N/A
  • 52 Week Low
  • IOVA $1.64
  • THRM $22.75
  • 52 Week High
  • IOVA $12.51
  • THRM $55.36
  • Technical
  • Relative Strength Index (RSI)
  • IOVA 53.63
  • THRM 54.24
  • Support Level
  • IOVA $1.70
  • THRM $31.00
  • Resistance Level
  • IOVA $4.33
  • THRM $34.75
  • Average True Range (ATR)
  • IOVA 0.40
  • THRM 1.24
  • MACD
  • IOVA -0.01
  • THRM -0.07
  • Stochastic Oscillator
  • IOVA 37.26
  • THRM 40.12

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About THRM Gentherm Inc

Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the United States, China, South Korea, Germany, Japan, the Czech Republic, and other countries.

Share on Social Networks: